Verfügbarkeit: Sphingolipids in disease

Sphingolipids in disease:

Gespeichert in:

Bibliographische Detailangaben
Format:	Buch
Sprache:	English
Veröffentlicht:	Wien [u.a.] Springer 2013
Schriftenreihe:	Handbook of experimental pharmacology 216
Schlagworte:	Sphingolipide Pathogenese
Online-Zugang:	Inhaltsverzeichnis
Beschreibung:	VIII, 478 S. Ill., graph. Darst.
ISBN:	9783709115107

Internformat

MARC


LEADER	00000nam a2200000 cb4500
001	BV040943092
003	DE-604
005	20130521
007	t
008	130412s2013 ad\|\| \|\|\|\| 00\|\|\| eng d
020			\|a 9783709115107 \|9 978-3-7091-1510-7
035			\|a (OCoLC)844060127
035			\|a (DE-599)BVBBV040943092
040			\|a DE-604 \|b ger \|e rakwb
041	0		\|a eng
049			\|a DE-355 \|a DE-19
084			\|a XI 1701 \|0 (DE-625)152977:12907 \|2 rvk
245	1	0	\|a Sphingolipids in disease \|c Erich Gulbins ..., ed.
264		1	\|a Wien [u.a.] \|b Springer \|c 2013
300			\|a VIII, 478 S. \|b Ill., graph. Darst.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	1		\|a Handbook of experimental pharmacology \|v 216
650	0	7	\|a Sphingolipide \|0 (DE-588)4182242-0 \|2 gnd \|9 rswk-swf
650	0	7	\|a Pathogenese \|0 (DE-588)4115512-9 \|2 gnd \|9 rswk-swf
689	0	0	\|a Sphingolipide \|0 (DE-588)4182242-0 \|D s
689	0	1	\|a Pathogenese \|0 (DE-588)4115512-9 \|D s
689	0		\|8 1\p \|5 DE-604
700	1		\|a Gulbins, Erich \|e Sonstige \|4 oth
776	0	8	\|i Erscheint auch als \|n Online-Ausgabe \|z 978-3-7091-1511-4
830		0	\|a Handbook of experimental pharmacology \|v 216 \|w (DE-604)BV002390716 \|9 216
856	4	2	\|m Digitalisierung UB Regensburg \|q application/pdf \|u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025921807&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA \|3 Inhaltsverzeichnis
999			\|a oai:aleph.bib-bvb.de:BVB01-025921807
883	1		\|8 1\p \|a cgwrk \|d 20201028 \|q DE-101 \|u https://d-nb.info/provenance/plan#cgwrk

Datensatz im Suchindex

_version_	1804150246552371200
adam_text	Contents Part I Sphingolipids in Cancer Sphingosine Kinase/Sphingosine 1-Phosphate Signaling in Cancer Therapeutics and Drug Resistance ............................. 3 Shanmugam Panneer Selvam and Besim Ogretmen Using ASMase Knockout Mice to Model Human Diseases ........... 29 Guoqiang Hua and Richard Kolesnick New Perspectives on the Role of Sphingosine 1-Phosphate in Cancer ... 55 Susan Pyne and Nigel J. Pyne Sphingolipids and Response to Chemotherapy .................... 73 Marie-Thérèse Dimanche-Boitrel and Amélie Rebillard Lung Cancer and Lung Injury: The Dual Role of Ceramide ......... 93 Tzipora Goldkom, Samuel Chung, and Simone Filosto Sphingolipids Role in Radiotherapy for Prostate Cancer ........... 115 Carla Hajj and Adriana Haimovitz-Friedman Part II Sphingolipids in Cardio-Reno-vascular Diseases Sphingolipid Metabolism and Atherosclerosis .................... 133 Xian-Cheng Jiang and Jing Liu Cardiovascular Effects of Sphingosine-1-Phosphate (SIP) ........... 147 Bodo Levkau Cross Talk Between Ceramide and Redox Signaling: Implications for Endothelial Dysfunction and Renal Disease ...................... 171 Ріп -Lan Li and Yang Zhang viu Contents Part III Sphingolipids in Inflammation, Infection and Lung Diseases Sphingolipids in Lung Endothelial Biology and Regulation of Vascular Integrity ....................................... 201 Taimur Abbasi and Joe G.N. Garcia Sphingolipids in Acute Lung Injury ............................ 227 Stefan Uhlig and Yang Yang The Involvement of Sphingolipids in Chronic Obstructive Pulmonary Diseases ........................................ 247 Irina Petrache and Daniela N. Petrusca Ceramide in Cystic Fibrosis .................................. 265 Heike Grassmé, Joachim Riethmüller, and Erich Gulbins Regulation of the Sphingosine Kinase/Sphingosine 1-Phosphate Pathway ................................................. 275 K. Alexa Orr Gandy and Una M. Obeid Bacterial Infections and Ceramide ............................. 305 Heike Grassmé and Katrin Anne Becker Viral Infections and Sphingolipids ............................. 321 Jürgen Schneider-Schaulies and Sibylle Schneider-Schaulies Ceramide in Plasma Membrane Repair ......................... 341 Annette Draeger and Eduard B. Babiychuk Sphingolipids and Inflammatory Diseases of the Skin .............. 355 Burkhard Kleuser and Lukasz Japtok Sphingolipids in Obesity, Type 2 Diabetes, and Metabolic Disease ..... 373 S.B. Russo, J.S. Ross, and L.A. Cowart Part IV Sphingolipids in Neuro-psychiatry and Muscle Diseases Neuronal Forms of Gaucher Disease ........................... 405 Einat B. Vitner and Anthony H. Futerman Sphingolipids in Neuroinflammation ........................... 421 Laura Davies, Klaus Fassbender, and Silke Walter Sphingolipids in Psychiatric Disorders and Pain Syndromes ......... 431 C. Mühle, M. Reichel, E. Gulbins, and J. Kornhuber Role of Sphingosine 1-Phosphate in Skeletal Muscle Cell Biology ..... 457 Paola Bruni and Chiara Donati Index ................................................... 469
any_adam_object	1
building	Verbundindex
bvnumber	BV040943092
classification_rvk	XI 1701
ctrlnum	(OCoLC)844060127 (DE-599)BVBBV040943092
discipline	Medizin
format	Book
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01583nam a2200385 cb4500</leader><controlfield tag="001">BV040943092</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130521 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">130412s2013 ad\|\| \|\|\|\| 00\|\|\| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783709115107</subfield><subfield code="9">978-3-7091-1510-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)844060127</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040943092</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1701</subfield><subfield code="0">(DE-625)152977:12907</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sphingolipids in disease</subfield><subfield code="c">Erich Gulbins ..., ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Wien [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 478 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Handbook of experimental pharmacology</subfield><subfield code="v">216</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sphingolipide</subfield><subfield code="0">(DE-588)4182242-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pathogenese</subfield><subfield code="0">(DE-588)4115512-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Sphingolipide</subfield><subfield code="0">(DE-588)4182242-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pathogenese</subfield><subfield code="0">(DE-588)4115512-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gulbins, Erich</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-3-7091-1511-4</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Handbook of experimental pharmacology</subfield><subfield code="v">216</subfield><subfield code="w">(DE-604)BV002390716</subfield><subfield code="9">216</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025921807&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025921807</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection>
id	DE-604.BV040943092
illustrated	Illustrated
indexdate	2024-07-10T00:35:53Z
institution	BVB
isbn	9783709115107
language	English
oai_aleph_id	oai:aleph.bib-bvb.de:BVB01-025921807
oclc_num	844060127
open_access_boolean
owner	DE-355 DE-BY-UBR DE-19 DE-BY-UBM
owner_facet	DE-355 DE-BY-UBR DE-19 DE-BY-UBM
physical	VIII, 478 S. Ill., graph. Darst.
publishDate	2013
publishDateSearch	2013
publishDateSort	2013
publisher	Springer
record_format	marc
series	Handbook of experimental pharmacology
series2	Handbook of experimental pharmacology
spelling	Sphingolipids in disease Erich Gulbins ..., ed. Wien [u.a.] Springer 2013 VIII, 478 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Handbook of experimental pharmacology 216 Sphingolipide (DE-588)4182242-0 gnd rswk-swf Pathogenese (DE-588)4115512-9 gnd rswk-swf Sphingolipide (DE-588)4182242-0 s Pathogenese (DE-588)4115512-9 s 1\p DE-604 Gulbins, Erich Sonstige oth Erscheint auch als Online-Ausgabe 978-3-7091-1511-4 Handbook of experimental pharmacology 216 (DE-604)BV002390716 216 Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025921807&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk
spellingShingle	Sphingolipids in disease Handbook of experimental pharmacology Sphingolipide (DE-588)4182242-0 gnd Pathogenese (DE-588)4115512-9 gnd
subject_GND	(DE-588)4182242-0 (DE-588)4115512-9
title	Sphingolipids in disease
title_auth	Sphingolipids in disease
title_exact_search	Sphingolipids in disease
title_full	Sphingolipids in disease Erich Gulbins ..., ed.
title_fullStr	Sphingolipids in disease Erich Gulbins ..., ed.
title_full_unstemmed	Sphingolipids in disease Erich Gulbins ..., ed.
title_short	Sphingolipids in disease
title_sort	sphingolipids in disease
topic	Sphingolipide (DE-588)4182242-0 gnd Pathogenese (DE-588)4115512-9 gnd
topic_facet	Sphingolipide Pathogenese
url	http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=025921807&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link	(DE-604)BV002390716
work_keys_str_mv	AT gulbinserich sphingolipidsindisease

Verfügbarkeit

Es ist kein Print-Exemplar vorhanden.

Fernleihe Bestellen Achtung: Nicht im THWS-Bestand! Inhaltsverzeichnis

MARC

Datensatz im Suchindex

Es ist kein Print-Exemplar vorhanden.

Ähnliche Einträge